Insider Transactions Reported by 17 Insiders of RHYTHM PHARMACEUTICALS, INC.

Symbol
RYTM on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

RHYTHM PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David P. Meeker President and CEO, Director $29,698,128 -$2,837,333 -8.7% 11 Feb 2026
Hunter C. Smith Chief Financial Officer $12,546,944 -$9,748,524 -44% 17 Feb 2026
Yann Mazabraud EVP, Head of International $6,074,447 -$5,382,716 -47% 14 Feb 2026
Pamela J. Cramer Chief Human Resources Officer $3,775,890 -$6,503,690 -63% 11 Feb 2026
Jennifer Kayden Lee EVP, Head of North America $3,040,334 11 Feb 2026
Joseph Shulman Chief Technical Officer $2,775,638 -$6,229,323 -69% 11 Feb 2026
Alastair Garfield Chief Scientific Officer $2,371,002 -$85,483 -3.5% 11 Feb 2026
Edward T. Mathers Director $768,558 24 Jun 2025
Linda Shapiro Manning Chief Medical Officer $563,250 09 Feb 2022
Christopher Paul German Corporate Controller & CAO $494,363 -$608,388 -55% 11 Feb 2026
LYNN A. TETRAULT Director $421,260 24 Jun 2025
JENNIFER L. GOOD Director $421,260 24 Jun 2025
CHRISTOPHE JEAN Director $421,260 24 Jun 2025
DAVID W. J. MCGIRR Director $421,260 -$4,267,494 -91% 24 Jun 2025
Camille L. Bedrosian Director $421,260 24 Jun 2025
Stuart A. Arbuckle Director $421,260 24 Jun 2025
William T. Roberts Chief Accounting Officer $279,459 29 Mar 2023

Recent Insider Transactions by Companies or Individuals for RHYTHM PHARMACEUTICALS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.